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1 Introduction
Vitamin K was discovered in 1929 by DAM of
Freiburg University when he was conducting
research of fetometabolism in chickens. One of
the chicks developed symptoms suggestive of
scurvy, but which were not cured by administer-
ing vitamin C. After experimenting with several
factors DAM finally found that the scorbutic
symptoms could be cured by supplementing food
with clover leaves. The following year in 1930,
he found another factor in food which had the
effect of preventing bleeding and thus named it
"Koagulations vitamin" (Vitamin K).
It is now known that there are seven types of
Vitamin K ranging from Kl to K7. Those which
exist in nature are vitamin Kl and vitamin K2.
It is also known that the main source of vitamin
K for the living body is from food and entero-
bacteria. The main source of Vitamin Kl from
food is green vegetables, while Vitamin K2 is
found in enterobacteria.
Recently Martius and others have proved that
vitamin Kl is converted to vitamin K2 within
the living organism. It has therefore been con-
cluded that vitamin K2 is the form most preva-
lent in nature. In this paper, we emphasize the
importance of vitamin K to the mother and baby
during the perinatal period and report the fol-
lowing three studies:
a. Hepaplastin test values in the last stage of
pregnancy.
b. The correlation between maternal and neo-
natal Hepaplastin test values.
c. Transplacental passage of vitamin K.
2 Identification of the vitamin K dependant fac-
tor in the pregnant woman using the Hepaplastin
test
Vitamin K dependent coagulation factors all
produced in the liver include prothrombin (fac-
tor II), factor III, factor IX and factor X. During
the latter half of pregnancy all coagulation fac-
tors with the exception of factor XIII increase
by about 1.5 to 2 times (figure 1).
Observations of the changes in the mean values
of vitamin K dependant factors were made using
the Hepaplastin test (HPT). The HPT is a freeze-
drying test devies to measure and control the
change of factors produced in the liver which
has factor II (prothrombin), VII (proconvertin)
and X (Stuart Prower factor) i. e., vitamin K.
The HPT study was performed on 65 normal
pregnant women who were attending the Ob-
steric and Gynaecology Department of Hok-
kaido University Hospital or other referral hos-
pitals. The subjects were in the third to tenth
lunar month of pregnany. Blood drawn from the
antecubital vein was tested. About 4.5 ml of
blood was required and mixed with 0.5 ml of 3.8
percent Sodium Citrate. The results of the test
are as shown in figure 2. The clearly indicate
that the HPT value is 1.6 to 1.7 times higher
than that of normal non-pregnant people.
The pattern of the increase of vitamin K depen-
dant factors in pregnancy was also shown. In
the course of this study when measuring pro-
thrombin activity to evaluate the activity of vi-
tamin K dependant factors, we found that the
thrombotest method could not be used without
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Figure 2. Changes in the values of the Hepaplastin-Test during pregnancy.
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further dilution, as the activity was > 100%.
One further advantage of the HPT was the ability
to measure vitamin K activity in an undiluted
sample.
The results show that increase of vitamin K
dependant factors is one of the reasons for the
hypercoagulability found in pregnancy. We were
also able to demonstrate the changes in the en-
dogenous coagulation system during the course
of pregnancy.
3 Correlation between maternal and neonatal
HPT values
Recently much attention has been paid to intra-
cranial bleeding in infants resulting from vitamin
K deficiency. It was noted that in spite of pro-
phylaxis with vitamin K administration intra-
cranial haemorrhage still occured especially in
breastfed infants. It has therefore been postu-
lated that lack of vitamin K in mother's milk
might predispose to neonatal intracranial hae-
morrhage.
The obstetrics and gynaecology haematology
study group conducted studies on the relation-
ship between the mother's HPT value at delivery
and the HPT value measured in a venous blood
from the umbili cord. The members of the study
group were Dr. MASAHIRO MAKI of Akita Uni-
versity, Dr. KOICHI SHIRAKAWA of Fukuoka Uni-
versity, Dr. TosfflKO TfeRAO of Hamamatsu Med-
ical College and Dr. SfflGETO SUZUKI. The results
showed that in the 222 cases studied the average
value of maternal venous HPT was 151.10
+ 34.65 percent (figure 3).
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To study the possible relationship between higher
and lowest umbilical venous HPT (> or ^ 30%
of normal) and maternal HPT levels, the mothers
were devided into three groups. Those with a
value > 150% (the mean level of the whole
group), those with a value of below 120% (-ISD
below the mean) and those with a level between
these extremes (120-150%).
In the group of mothers whose HPT was under
120 percent the HPT level was under 30% in
33.3% of umbilical samples. In the babies of
mothers with HPT values between 120 to 150
percent 19.4% of umbilical samples were ̂  30%
of normal, whereas in those with a level of
> 150% in only 8.2% of the umbilical venous
samples had low levels of HPT (figure 4).
4 The relationship between the volume of blood
lost and the maternal HPT level at delivery
The relationship between the HPT at delivery
and the volume of blood-loss is shown in figure
5. This blood-loss at delivery is dependent on a
number of factors including uterine contractions,
and it is therefore quite difficult to quantify the
influence of coagulation factors including vita-
min K. However, when two groups, one with
maternal HPT more than 110 percent, and the
other with levels of HPT less than or equal to
110 percent were compared for abnormal blood-
less (more than 500 ml) at delivery, we noted
that 38.5% of the group with low HPT values
had abnormal blood-loss, whereas such abnor-
mal loss occurred in only 13.5% of those with
higher HPT value of > 110% (figure 6).
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Figure 3. Correlation between the value of HPT during delivery and cord venous blood.
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Figure 6. Incidence of abnormal maternal postpartum haemorrhage related to the value of maternal HPT during
delivery.
MAKI and others, using oral vitamin K2 in a
double-blind study, observed that when pregnant
women were given 20 mg daily for seven days,
the severity of blood-loss decreased markedly in
comparision to that found in a control group
given a placebe. We can therefore conclude that
coagulation produced by administered vitamin
K is clinically useful in pregnant women even
when used in excess.
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5 Passage of vitamin K through the placenta
VAN CREVELD and his group administered vita-
min K, to more than 10,000 mothers and re-
ported that the frequency of neonatal bleeding
(neonatal malaena) did not change. This study
concluded that vitamin K does not pass through
the placenta. However, according to the report
of SHEARER and others, vitamin K at the end of
pregnancy is present in a very small concentra-
tion that amount can hardly be detected (table
I). They also reported that a very small amount
of vitamin K (an average of 0.12 ng/ml) was
detected in umbilical venous blood after they
had given an infusion of vitamin K to the mother
about one hour before delivery (table II).
Table I. Concentration of Vkt in the maternal and
cord venous blood (SHEARER). (Vki = vitamin KO








































































However, in the present study, when an intra-
venous infusion of 60 mg of vitamin K2 was
administered to two patients who had elective
caesarean section deliveries for cephalo-pelvic
disproportion it was found that transfer of vi-
tamin K2 occurred:
Case 1: Patient A primigravid and 28 years old.
The concentration of plasma vitamin K2 rose to
a peak in one to three hours and declined in
seven to eight hours. The pattern is almost sim-
iliar to that of normal adults and newborn ba-
bies, and 5.3 ng/ml VK2 was detected in the
umbilical venous blood (figure 7).
Table Π. Concentration of Vki of cord venous blood
after administration of Vki 1 mg to the to the mothers.
(SHEARER) (Vkj = vitamin KI) 3hrs 12hrs
n.d. = not detected (< 0.10 ng/ml)
Figure 7. Concentration of Vk2 in cord venous blood,
after administrating to Vk2 60 mg to the mother before
Caesarean section.
(Vkj = vitamin K,
Vk2 = vitamin K2)
ο — ο concentration of Vk2 in the mother.
(case. I)
concentration of Vk2 in cord venous blood.
(case I)
concentration of Vk2 in the mother, (case II)
concentration of Vk2 in cord venous blood.
(case II)
©
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Case 2: Patient B primigravid and 40 years old.
Pregnant for ten months.
The fetus was in a quiet state, and she was given
a slow constant infusion of 60 mg of vitamin K2
together with 20 ml of glucose one hour before
the performance of the caesarean section. The
concentration of vitamin K2 in the plasma a
level of 11900 ng/ml was found to be highest just
after administration. The level of VK2 was 94
ng/ml in the umbilical venous blood.
The observations from these two case studies are
of great importance in view of the fact that, after
69 mg of vitamin K2 was administered by intra-
venous infusion six hours prior to surgery, a
concentration of 5.3 ng/ml of vitamin K2 was
detected in the umbilical venous blood.
Comparing these results with those of SHEARER
and others, there is a 60 fold difference between
the dose of vitamin Kl (1 mg) and that of vita-
min K2 (60 mg), and 5.3 ng/ml (equivalent to 44
times of the previously reported umbilical level
0.12 ng/ml) of vitamin K2 was detected.
In the second case, 60 mg of vitamin K2 together
with glucose was administered via a slow intra-
venous injection. A significantly greater amount
of vitamin K2 (94 ng/ml) was detected in the
umbilical blood of this baby compared to that
found in the first case. In the second case, the
baby was delivered one hour after the adminis-
tration of vitamin K2, and in the first case, the
baby was delivered six hours after administration
of vitamin K2.
The 94 ng/ml of vitamin K2 detected only one
hour after administration is 17 times the concen-
tration of vitamin K2 detected in the first case
(5.3 ng/ml) after six hours. This suggests that
vitamin K2 corsses the placenta immediately.
It is therefore evident that vitamin K2 crosses
the placenta though not in any great amount.
This might be due to a lower level of binding
lipoprotein in the fetus which reduces fetal up-
take.
We should mention that there are many problems
associated with the dosage and timing of admin-
istration of vitamin K2 and estimation of the
proportion likely to be transferred to the fetus.
It would seem to be necessary to investigate
decrease of uptake, as the lipoprotein level be-
comes lower as pregnancy advances.
Abstract
Little is known about the absorption, excretion and
transplacental transport of vitamin K in the perinatal
period.
From this point of view, the following studies were
carried out.
1) Hepaplastin tests were performed on 65 women in
the last stage of pregnancy and each coagulation
factor was estimated as well.
2) Correlations were made between mothers' and ba-
bies' Hepaplastin test values.
3) Transplacental transport of vitamin K2 was studied.
The general activity of vitamin K dependent factors in
pregnant women was much higher than in non preg-
nant women.
As far as the correlation between mothers' venous
blood during delivery and cord venous blood is con-
cerned, in the group of mothers with Hepaplastin test
value of less than 120% of the normal adult value, the
value of the Hepaplastin test was less than 30% of
normal adult value in the cord venous blood.
We also established that vitamin K passed through the
placenta but only in small qualities.
Keywords: Hepaplastin test (HPT), hypothrombinemia, postpartum hemorrhage, vitamin K.
Zusammenfassung
Metabolismus Vitamin K-abhängiger Faktoren bei Müt-
tern und ihren Neugeborenen
Über die Absorption, Exkretion und den transplazen-
taren Transport von Vitamin K in der Perinatalperiode
ist wenig bekannt.
Unter diesem Aspekt wurden folgende Untersuchun-
gen durchgeführt:
1) Bei 65 Frauen wurden am Ende der Schwanger-
schaft Hepaplastin-Tests durchgeführt und die ver-
schiedenen Gerinnungsfaktoren bestimmt.
2) Wir korrelierten die Ergebnisse der Hepaplastin-
Tests der Mütter mit denen der Neugeborenen.
3) Der transplazentare Transport von Vitamin K2
wurde untersucht.
Generell war die Aktivität von Vitamin K-abhängigen
Faktoren bei Schwangeren sehr viel höher als bei
nichtschwangeren Frauen.
Betrachtet man die Korrelation der Werte zwischen
mütterlichem Venenblut unter der Geburt und dem
J. Perinat. Med. 17 (1989)
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Nabelvenenblut, gilt folgendes: in der Gruppe der Müt-
ter mit Hepaplastin-Test-Werten von weniger als 120%
als die von normalen Erwachsenen hatten deren
Kinder im Nabelvenenblut Hepaplastin-Test-Werte
von weniger als 30% gegenüber dem Normalwert bei
Erwachsenen.
Wir konnten ebenfalls nachweisen, daß Vitamin K die
Plazenta nur in geringem Umfang passiert.
Schlüsselwörter: Hepaplastin-Test (HPT), Hypothrombinaemie, Nachgeburtsblutung, Vitamin K.
Resume
Metabolisme des facteurs dependants de la vitamine K
chez les meres et leurs nouveaux-nes
On connait peu de choses concernant l'absorption,
Pexcretion et le transport transplacentaire de la vita-
mine K en periode perinatale. Dans cette optique les
etudes suivantes ont ete realisees.
l — Les tests d'hepaplastine ont ete effectues chez 65
femmes en fin de grossesse et chaque facteur de
coagulation a ete dose.
2— Des correlations ont te cherchees entre les valeurs
des tests d'hepaplastine des meres et de leurs en-
fants.
3— Le transport transplacentaire de vitamine K2 a
ete etudie.
L'activite generate des facteurs dependants de la vita-
mine K est beaucoup plus elevee chez les femmes en-
ceintes que chez les femmes en dehors de la grossesse.
II y a une correlation entre le sang veineux des meres
au cours de l'accouchement et le sang veineux du
cordon, en effet, dans le groupe des meres ayant des
valeurs du test d'hepaplastine de moins de 120% des
valeurs de Fadulte normal, les valeurs des tests d'he-
paplastine au sang veineux du cordon sont inferieures
a 30% des valeurs de Fadulte normal.
Nous avons egalement etabli que la vitamine K tra-
verse le placenta mais seulement en petites quantites.
Mots-cles: Hypoprothrombinemie, hemorrhagie du post partum, test d'hepaplastine, vitamine K.
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